The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gain of ALK gene copy number to predict lack of response to anti-EGFR treatment in advanced chemorefractory colorectal cancer (CRC) with KRAS/NRAS/BRAF/PI3KCA wild-type status.
Filippo Pietrantonio
No relevant relationships to disclose
Anna Tessari
No relevant relationships to disclose
Rosalba Miceli
No relevant relationships to disclose
Pamela Biondani
No relevant relationships to disclose
Federica Perrone
No relevant relationships to disclose
Adele Testi
No relevant relationships to disclose
Elena Tamborini
No relevant relationships to disclose
Giuseppe Pelosi
No relevant relationships to disclose
Luigi Mariani
No relevant relationships to disclose
Giuseppe Fanetti
No relevant relationships to disclose
Arpine Gevorgyan
No relevant relationships to disclose
Ilaria Bossi
No relevant relationships to disclose
Maria Di Bartolomeo
No relevant relationships to disclose
Filippo G. De Braud
No relevant relationships to disclose